|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Mol Cell
12:1379-1389
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor.
|
|
J.Hu,
J.Liu,
R.Ghirlando,
A.R.Saltiel,
S.R.Hubbard.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The adaptor protein APS is a substrate of the insulin receptor and couples
receptor activation with phosphorylation of Cbl to facilitate glucose uptake.
The interaction with the activated insulin receptor is mediated by the Src
homology 2 (SH2) domain of APS. Here, we present the crystal structure of the
APS SH2 domain in complex with the phosphorylated tyrosine kinase domain of the
insulin receptor. The structure reveals a novel dimeric configuration of the APS
SH2 domain, wherein the C-terminal half of each protomer is structurally
divergent from conventional, monomeric SH2 domains. The APS SH2 dimer engages
two kinase molecules, with pTyr-1158 of the kinase activation loop bound in the
canonical phosphotyrosine binding pocket of the SH2 domain and a second
phosphotyrosine, pTyr-1162, coordinated by two lysine residues in beta strand D.
This structure provides a molecular visualization of one of the initial
downstream recruitment events following insulin activation of its dimeric
receptor.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Crystal Structure of the APS(SH2)-IRK
ComplexRibbon diagram (top) and all-atom representation (bottom)
of the APS(SH2)-IRK structure. The noncrystallographic 2-fold
axis is vertical. The two IRK molecules are colored cyan, except
for the activation loop, which is colored yellow. The two
APS(SH2) protomers are colored green and purple. The three
phosphotyrosine residues in the IRK activation loop are shown in
ball-and-stick representation, with carbon atoms colored yellow,
oxygen atoms colored red, and phosphorus atoms colored
black. The bisubstrate inhibitor is colored orange, with the
peptide portion shown in ribbon/coil representation, and the
substrate tyrosine, linker, and ATPÎłS atoms shown in
ball-and-stick representation. The N termini of the IRK
molecules, which lead into the juxtamembrane region (34 residues
to the transmembrane helix), are indicated, as are the C termini
of the APS(SH2) protomers. The C-terminal tyrosine
phosphorylation site in APS (Tyr-618) is 132 residues from the
end of the SH2 domain.
|
 |
Figure 3.
Figure 3. Mode of Binding of the IRK Activation Loop to the
APS SH2 Domain(A) Stereo view of the interactions between
APS(SH2) and the IRK activation loop. The IRK activation loop is
colored yellow and the APS SH2 protomer to which it binds is
colored green. For clarity, the other APS SH2 protomer is not
shown. Hydrogen bonds/salt bridges are shown with black dashed
lines.(B) Path of the IRK activation loop across the APS SH2
domain surface. A ribbon diagram of the APS SH2 dimer is shown,
with the two protomers colored green and purple. The Cα trace
of the IRK activation loop proximal to pTyr-1158 and pTyr-1162
is colored yellow, with the side chains of the two
phosphotyrosines shown in ball-and-stick representation. The SH2
domains of Src (Waksman et al., 1993) and Grb2 (Rahuel et al.,
1996) with bound peptides were superimposed (core ÎČ sheets)
with the green APS SH2 protomer, and the phosphopeptides from
the superposition, PQpYEEI for Src (cyan) and PSp YVNVQN for
Grb2 (orange), are displayed as Cα traces, with the
phosphotyrosines shown in ball-and-stick representation. The N-
and C termini of the phosphopeptides are indicated by âNâ
and âCâ of the appropriate color. The two disordered
residues between ÎČD and αB in the APS SH2 protomers are
represented by small spheres.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2003,
12,
1379-1389)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Leto,
and
A.R.Saltiel
(2012).
Regulation of glucose transport by insulin: traffic control of GLUT4.
|
| |
Nat Rev Mol Cell Biol,
13,
383-396.
|
 |
|
|
|
|
 |
F.Vlad,
M.J.Droillard,
B.Valot,
M.Khafif,
A.Rodrigues,
M.Brault,
M.Zivy,
P.L.Rodriguez,
S.Merlot,
and
C.Laurière
(2010).
Phospho-site mapping, genetic and in planta activation studies reveal key aspects of the different phosphorylation mechanisms involved in activation of SnRK2s.
|
| |
Plant J,
63,
778-790.
|
 |
|
|
|
|
 |
D.F.Ceccarelli,
and
F.Sicheri
(2009).
Grb-ing hold of insulin signaling.
|
| |
Nat Struct Mol Biol,
16,
803-804.
|
 |
|
|
|
|
 |
R.S.Depetris,
J.Wu,
and
S.R.Hubbard
(2009).
Structural and functional studies of the Ras-associating and pleckstrin-homology domains of Grb10 and Grb14.
|
| |
Nat Struct Mol Biol,
16,
833-839.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Gery,
Q.Cao,
S.Gueller,
H.Xing,
A.Tefferi,
and
H.P.Koeffler
(2009).
Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
|
| |
J Leukoc Biol,
85,
957-965.
|
 |
|
|
|
|
 |
S.Hanke,
and
M.Mann
(2009).
The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2.
|
| |
Mol Cell Proteomics,
8,
519-534.
|
 |
|
|
|
|
 |
T.Hunter
(2009).
Tyrosine phosphorylation: thirty years and counting.
|
| |
Curr Opin Cell Biol,
21,
140-146.
|
 |
|
|
|
|
 |
A.Belfiore,
and
F.Frasca
(2008).
IGF and insulin receptor signaling in breast cancer.
|
| |
J Mammary Gland Biol Neoplasia,
13,
381-406.
|
 |
|
|
|
|
 |
A.C.Pike,
P.Rellos,
F.H.Niesen,
A.Turnbull,
A.W.Oliver,
S.A.Parker,
B.E.Turk,
L.H.Pearl,
and
S.Knapp
(2008).
Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites.
|
| |
EMBO J,
27,
704-714.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Frasca,
G.Pandini,
L.Sciacca,
V.Pezzino,
S.Squatrito,
A.Belfiore,
and
R.Vigneri
(2008).
The role of insulin receptors and IGF-I receptors in cancer and other diseases.
|
| |
Arch Physiol Biochem,
114,
23-37.
|
 |
|
|
|
|
 |
J.Wu,
W.Li,
B.P.Craddock,
K.W.Foreman,
M.J.Mulvihill,
Q.S.Ji,
W.T.Miller,
and
S.R.Hubbard
(2008).
Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.
|
| |
EMBO J,
27,
1985-1994.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Wu,
Y.D.Tseng,
C.F.Xu,
T.A.Neubert,
M.F.White,
and
S.R.Hubbard
(2008).
Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2.
|
| |
Nat Struct Mol Biol,
15,
251-258.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Chen,
J.Takita,
Y.L.Choi,
M.Kato,
M.Ohira,
M.Sanada,
L.Wang,
M.Soda,
A.Kikuchi,
T.Igarashi,
A.Nakagawara,
Y.Hayashi,
H.Mano,
and
S.Ogawa
(2008).
Oncogenic mutations of ALK kinase in neuroblastoma.
|
| |
Nature,
455,
971-974.
|
 |
|
|
|
|
 |
G.Kozlov,
P.Peschard,
B.Zimmerman,
T.Lin,
T.Moldoveanu,
N.Mansur-Azzam,
K.Gehring,
and
M.Park
(2007).
Structural basis for UBA-mediated dimerization of c-Cbl ubiquitin ligase.
|
| |
J Biol Chem,
282,
27547-27555.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Kishi,
K.Mawatari,
K.Sakai-Wakamatsu,
T.Yuasa,
M.Wang,
M.Ogura-Sawa,
Y.Nakaya,
S.Hatakeyama,
and
Y.Ebina
(2007).
APS-mediated ubiquitination of the insulin receptor enhances its internalization, but does not induce its degradation.
|
| |
Endocr J,
54,
77-88.
|
 |
|
|
|
|
 |
S.Donatello,
A.Fiorino,
D.Degl'Innocenti,
L.Alberti,
C.Miranda,
L.Gorla,
I.Bongarzone,
M.G.Rizzetti,
M.A.Pierotti,
and
M.G.Borrello
(2007).
SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
|
| |
Oncogene,
26,
6546-6559.
|
 |
|
|
|
|
 |
S.Huang,
and
M.P.Czech
(2007).
The GLUT4 glucose transporter.
|
| |
Cell Metab,
5,
237-252.
|
 |
|
|
|
|
 |
S.R.Hubbard,
and
W.T.Miller
(2007).
Receptor tyrosine kinases: mechanisms of activation and signaling.
|
| |
Curr Opin Cell Biol,
19,
117-123.
|
 |
|
|
|
|
 |
T.Pawson,
and
N.Warner
(2007).
Oncogenic re-wiring of cellular signaling pathways.
|
| |
Oncogene,
26,
1268-1275.
|
 |
|
|
|
|
 |
A.M.Burza,
I.Pekala,
J.Sikora,
P.Siedlecki,
P.MaĆagocki,
M.Bucholc,
L.Koper,
P.Zielenkiewicz,
M.Dadlez,
and
G.Dobrowolska
(2006).
Nicotiana tabacum osmotic stress-activated kinase is regulated by phosphorylation on Ser-154 and Ser-158 in the kinase activation loop.
|
| |
J Biol Chem,
281,
34299-34311.
|
 |
|
|
|
|
 |
B.A.Liu,
K.Jablonowski,
M.Raina,
M.Arcé,
T.Pawson,
and
P.D.Nash
(2006).
The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling.
|
| |
Mol Cell,
22,
851-868.
|
 |
|
|
|
|
 |
B.T.Seet,
I.Dikic,
M.M.Zhou,
and
T.Pawson
(2006).
Reading protein modifications with interaction domains.
|
| |
Nat Rev Mol Cell Biol,
7,
473-483.
|
 |
|
|
|
|
 |
G.Swaminathan,
and
A.Y.Tsygankov
(2006).
The Cbl family proteins: ring leaders in regulation of cell signaling.
|
| |
J Cell Physiol,
209,
21-43.
|
 |
|
|
|
|
 |
J.H.Kurzer,
P.Saharinen,
O.Silvennoinen,
and
C.Carter-Su
(2006).
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.
|
| |
Mol Cell Biol,
26,
6381-6394.
|
 |
|
|
|
|
 |
C.J.Porter,
M.C.Wilce,
J.P.Mackay,
P.Leedman,
and
J.A.Wilce
(2005).
Grb7-SH2 domain dimerisation is affected by a single point mutation.
|
| |
Eur Biophys J,
34,
454-460.
|
 |
|
|
|
|
 |
J.Hu,
and
S.R.Hubbard
(2005).
Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
|
| |
J Biol Chem,
280,
18943-18949.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.D.Katsanakis,
and
T.S.Pillay
(2005).
Cross-talk between the two divergent insulin signaling pathways is revealed by the protein kinase B (Akt)-mediated phosphorylation of adapter protein APS on serine 588.
|
| |
J Biol Chem,
280,
37827-37832.
|
 |
|
|
|
|
 |
L.J.Holt,
and
R.J.Daly
(2005).
Adapter protein connections: the MRL and Grb7 protein families.
|
| |
Growth Factors,
23,
193-201.
|
 |
|
|
|
|
 |
M.Nishi,
E.D.Werner,
B.C.Oh,
J.D.Frantz,
S.Dhe-Paganon,
L.Hansen,
J.Lee,
and
S.E.Shoelson
(2005).
Kinase activation through dimerization by human SH2-B.
|
| |
Mol Cell Biol,
25,
2607-2621.
|
 |
|
|
|
|
 |
P.Bhanot,
K.Schauer,
I.Coppens,
and
V.Nussenzweig
(2005).
A surface phospholipase is involved in the migration of plasmodium sporozoites through cells.
|
| |
J Biol Chem,
280,
6752-6760.
|
 |
|
|
|
|
 |
R.S.Depetris,
J.Hu,
I.Gimpelevich,
L.J.Holt,
R.J.Daly,
and
S.R.Hubbard
(2005).
Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.
|
| |
Mol Cell,
20,
325-333.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Canagarajah,
F.C.Leskow,
J.Y.Ho,
H.Mischak,
L.F.Saidi,
M.G.Kazanietz,
and
J.H.Hurley
(2004).
Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin.
|
| |
Cell,
119,
407-418.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Duan,
H.Yang,
M.F.White,
and
L.Rui
(2004).
Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.
|
| |
Mol Cell Biol,
24,
7435-7443.
|
 |
|
|
|
|
 |
C.Marshall,
and
W.Müller-Esterl
(2004).
Spotlight on cellular signaling.
|
| |
Mol Cell,
15,
849-852.
|
 |
|
|
|
|
 |
K.Duda,
Y.I.Chi,
and
S.E.Shoelson
(2004).
Structural basis for HNF-4alpha activation by ligand and coactivator binding.
|
| |
J Biol Chem,
279,
23311-23316.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Chang,
S.H.Chiang,
and
A.R.Saltiel
(2004).
Insulin signaling and the regulation of glucose transport.
|
| |
Mol Med,
10,
65-71.
|
 |
|
|
|
|
 |
M.A.Lemmon,
and
S.J.Smerdon
(2004).
Signaling by the sea.
|
| |
Nat Struct Mol Biol,
11,
682-685.
|
 |
|
|
|
|
 |
S.Dhe-Paganon,
E.D.Werner,
M.Nishi,
L.Hansen,
Y.I.Chi,
and
S.E.Shoelson
(2004).
A phenylalanine zipper mediates APS dimerization.
|
| |
Nat Struct Mol Biol,
11,
968-974.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |